In the development of the GLP-1 receptor agonist, semaglutide, the strategy used to extend the drugs half-life was to promote covalent and non-covalent binding of semaglutide to albumin through the addition of a fatty-acid attachment on semaglutide
M.StorerR
Can it Cause Weight Gains
Glossary Off-label prescribing: Using an approved medicine for a purpose, dose, or population not specifically listed on its official approval CDSCO: Central Drugs Standard Control Organisation Indias national pharmaceutical regulator Grey market: Unauthorized sale of a genuine or counterfeit drug outside licensed, regulated channels Sarcopenia: Loss of muscle mass and strength, a key risk during rapid weight loss BMI: Body Mass Index, a simple weight-to-height ratio used to classify body weight categories External References Han SH, Safeek R, Ockerman K, et al
Warfarin interaction is clinically relevant because GLP-1-induced changes in gastric emptying can alter absorption of narrow-therapeutic-index drugs, and QT prolongation matters because of the cardiac side-effect profile of some weight-loss adjuncts
Ashwagandha: Usefulness and Safety
